Cidara Therapeutics Inc

NASDAQ:CDTX

12.51

-0.17 (-1.34%)

6:44:02 PM EDT: $12.00 -0.51 (-4.08%)

Market Cap (Intraday)	56.30M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$13.05 Million
Adjusted EPS	-$1.30

See more estimates

10-Day MA	$12.72
50-Day MA	$15.06
200-Day MA	$16.23

See more pivots

Cidara Therapeutics Inc Stock, NASDAQ:CDTX

6310 Nancy Ridge Drive, Suite 101, San Diego, California 92121

United States of America

Phone: +1.858.752.6170

Number of Employees: 69

http://www.cidara.com

Description

Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.